周四，摩根士丹利重申对Vir Biotechnology（NASDAQ:VIR）股票的"增持"评级和20.00美元的目标价，较当前7.14美元的价格有显著上涨空间。根据InvestingPro数据，分析师目标价区间在14美元至110美元之间，反映出尽管近期市场面临挑战，但分析师对公司前景仍充满信心。该公司分析师强调，Phase 3 ECLIPSE试验已开始招募患者，标志着Vir ...

Biotechnology has been in use by humans for over 10,000 years. Ancient bioscience incorporated processes like fermentation ...

Scotland’s rich culinary heritage ​is vital for the country’s economy – but it needs to be future-proofed, writes Dr Liz ...

There are plenty of choices in the Sector - Health category, but where should you start your research? Well, one fund that might be worth investigating is Franklin Biotechnology Discovery A (FBDIX).

Mar. 10, 2025 — Researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a potential therapeutic target in ...

The School of Biotechnology, University of Jammu, recently held an Advisory Committee Meeting to evaluate and enhance its ...

National Testing Agency (NTA) has invited applications for the Biotechnology Eligibility Test (BET) 2025, the National Level ...

Montgomery College has received approval from the Maryland Apprenticeship and Training Council (MATC) to become a sponsor of ...

West Lafayette, Ind.- Purdue University President Mung Chiang welcomed Dominican Republic President Luis Abinader and his ...

VIR's T-cell engagers have potential in oncology and showed promise with initial data in January 2025. Read my thoughts about ...

Pre-earnings options volume in Sana Biotechnology (SANA) is 2.0x normal with calls leading puts 150:1. Implied volatility suggests the market ...

Unity Biotechnology (NASDAQ:UBX – Get Free Report)‘s stock had its “buy” rating reissued by Chardan Capital in a research ...